AXIAL SPONDYLOARTHRITIS

This Phase 2 study tests an experimental drug called SPY002-072 in 285 adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis. Participants receive either the drug or a placebo, and researchers measure changes in disease ac…

This study is testing the long-term safety and effectiveness of bimekizumab, a drug that reduces inflammation, in 508 adults with active axial spondyloarthritis (including ankylosing spondylitis). Participants who completed earlier trials will receive the drug for an extended per…

This phase 3 trial tests whether the drug filgotinib, taken as a daily pill, can reduce symptoms of active axial spondyloarthritis—a type of arthritis that causes back pain and stiffness. About 495 adults with the condition will receive either filgotinib (200 mg or 100 mg) or a p…

This study looks at whether walking football—a low-impact, no-running version of soccer—is safe and helpful for people with axial spondyloarthritis, a long-term inflammatory spine condition. Twelve participants will play twice a week for 12 weeks. Researchers will measure pain, s…

This study looks at whether adding acupuncture to usual care can reduce spinal pain in people with axial spondyloarthritis who did not get relief from NSAIDs. About 140 adults in Singapore will either receive standard rheumatology care or standard care plus acupuncture. The main …

This study follows 250 people with long-term back pain who may have early axial spondyloarthritis, a type of inflammatory arthritis. Researchers want to learn how the disease develops and whether a 6-month rehab program with a physiotherapist can help. The goal is to reduce the y…